The Lupus Forum

The Lupus Forum

Welcome to the Lupus Forum. The Lupus Forum is an educational website developed under the auspices of the University of Leeds and is dedicated to the dissemination of the latest developments in the field of lupus. It provides continuing medical education to clinicians around the globe to facilitate greater understanding of lupus, its treatments, and clinical practice.

Určitě navštivte web podcastu a podpořte jeho tvůrce: soundcloud.com

Autor

The Lupus Forum

Kategorie

Education

Web podcastu

soundcloud.com

Nejnovější epizoda

11. lis 2026

Kde poslouchat?

Podcasty v aplikaci Replaio Radio Už brzy

Podcasty míří do aplikace už brzy. Nainstaluj si ji teď a jako první uvidíš úplně nový pohled na podcasty

Stáhnout z Google Play Nainstaluj zdarma Android 10 mil.+ stažení · hodnocení 4,7+ iOS už brzy

Epizody

EULAR 2026 Day 2 Highlights Podcast 04.06.2026

Join Professor Chris Edwards as he summarises his top lupus abstracts, posters, and presentations for Day 2 of EULAR 2026 (Thursday, June 4th).

EULAR 2026 Day 1 Highlights 03.06.2026

Join Professor Chris Edwards as he summarises his top lupus abstracts, posters, and presentations for Day 1 of EULAR 2026 (Wednesday, June 3rd).

EULAR 2026 Preview Podcast 28.05.2026

Join Professor Chris Edwards as he previews what we are most looking forward to this EULAR, introducing some of the top abstracts and posters we’ve chosen so that you can better plan your time at what will be a busy and exciting congress.

Discussing Lupus: Antimalarial use in lupus nephritis and CAR T-cell therapy in SLE 08.05.2026

Professor Eric Morand and Doctor Kathryn Connelly discuss two recent studies advancing the treatment landscape in SLE and lupus nephritis. This episode discusses antimalarial use and extra-renal damage accrual in lupus nephritis, as well as autologous CD19 CAR T-cell therapy for paediatric and adult SLE. Through expert-led discussion, this podcast offers practical perspectives for clinicians looki...

Guiding lupus clinical management: Renal manifestations and lupus nephritis 28.04.2026

Tune into this episode of our 'Guiding lupus clinical management' podcast series and hear from Professors Ed Vital, Liz Lightstone and Brad Rovin as they discuss ACR and EULAR guidance on renal manifestations of lupus and lupus nephritis, along with what that means in practice.

Discussing Lupus: S1PR1-mediated modulation as a treatment target, and obinutuzumab results in SLE 09.04.2026

Professor Ed Vital and Professor Chris Edwards discuss two recent studies advancing the treatment landscape in SLE. This episode discusses S1PR1-mediated modulation of immune cell trafficking as a potential upstream therapeutic strategy in SLE, and the efficacy and safety of obinutuzumab when added to standard therapy in adults with active SLE. Through expert-led discussion, this podcast offers pr...

Discussing Lupus: New Phase 2 evidence in SLE and lupus nephritis 18.03.2026

Professor Victoria Werth and Professor Chi-Chiu Mok discuss two recent studies advancing the treatment landscape in SLE and lupus nephritis. This episode reviews findings from the Phase 2 TULIP-LN trial, highlighting how anifrolumab treatment leads to rapid reductions in urinary biomarkers of intrarenal inflammation in lupus nephritis, and discusses a single-arm Phase 2 trial evaluating daratumuma...

Discussing Lupus: New treatment safety and efficacy and impact of mental health outcomes in SLE 13.02.2026

Professor Victoria Werth and Doctor Guillermo J. Pons-Estel highlights the new treatment safety and efficacy and impact of mental health outcomes in SLE. This podcast discusses efficacy and safety of SC anifrolumab in SLE, and the associations between discrimination and PROs and the role of mental health in these associations among a multiracial, multiethnic cohort with SLE. If you are interested...

Discussing Lupus: CM313 and predictors of damage in accrual in SLE 24.12.2025

Professor Ed Vital discusses two key publications covered on the Lupus Forum in December. his podcast reviews data from a randomised, double-blind, placebo-controlled Phase Ib/IIa trial of the anti-CD38 monoclonal antibody CM313 in adults with systemic lupus erythematosus (SLE), focusing on safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and preliminary efficacy. The epis...

Discussing Lupus: Belimumab and CD19 CAR NK-cell therapy in systemic lupus erythematosus 23.12.2025

Professor Richard Furie and Doctor Guillermo J. Pons-Estel review two key publications covered on the Lupus Forum in November. This podcast reports data from a multicentre, randomised, double-blind, placebo-controlled trial evaluating low-dose belimumab in patients with systemic lupus erythematosus (SLE), with a focus on disease flare prevention. The episode also reports findings on the efficacy a...

Discussing Lupus: Emerging treatments in SLE and LN 04.12.2025

Professor Vibeke Strand highlights the emerging treatments in SLE and LN. This podcast reports the efficacy and safety results of a Phase 3 trial of telitacicept at a dose of 160mg weekly as compared with PBO in Chinese persons with active SLE. The efficacy and safety of SC secukinumab 300mg compared with PBO, in combination with the SoC, in patients with active LN is also reported. If you are int...

Early Use of Advanced Therapies in Lupus: Highlights Podcast 27.11.2025

Join Professor Ed Vital, Dr Guillermo J. Pons-Estel, Professor Richard Furie and Professor Chris Edwards on the Lupus Forum for their discussion of the recent webinar “Early use of advanced therapies in lupus”. Watch them discuss key highlights from the webinar, including limitations of SoC, insights from clinical trials and strategies for early intervention with advanced therapies. Visit www.lupu...

Lupus at ACR 2025: Review Podcast 06.11.2025

Join Professors Ed Vital and Maria Dall'Era as they review their highlights of the recent ACR 2025 congress, watch them discuss their abstracts and highlight key information.

ACR 2025 Highlights: Day 4 29.10.2025

Join Professor Ed Vital as he summarises his top abstracts, posters, and presentations from Day 4 of ACR 2025 (Wednesday, October 29th).

ACR 2025 Highlights: Day 3 28.10.2025

Join Professor Ed Vital as he summarises his top abstracts, posters, and presentations from Day 3 of ACR 2025 (Tuesday, October 28th).

ACR 2025 Highlights: Day 2 27.10.2025

Join Professor Ed Vital as he summarises his top abstracts, posters, and presentations from Day 2 of ACR 2025 (Monday, October 27th).

ACR 2025 Highlights: Day 1 26.10.2025

Join Professor Ed Vital as he summarises his top abstracts, posters, and presentations from Day 1 of ACR 2025 (Sunday, October 26th).

Discussing Lupus: EULAR recommendations and long-term efficacy/safety of JAKis or BTKs 23.10.2025

Join Professor Chris Edwards and Doctor Alice Mason as they discuss EULAR recommendations for a core dataset in SLE and efficacy and safety of upadacitinib as a monotherapy or combination with elsubrutinib for SLE. This podcast provides a valuable framework for guiding therapeutic decisions in SLE, and also supporting clinical care, translational/observation research. If you are interested in the...

Lupus at ACR 2025: Preview Podcast 21.10.2025

Join Professors Ed Vital and Maria Dall'Era as they preview what they are most looking forward to this ACR, introducing some of the top abstracts and posters we’ve chosen so that you can better plan your time at what will be a busy and exciting congress.

Discussing Lupus: Therapeutic strategies and emerging treatments in SLE and LN 10.10.2025

Professor Eric Morand and Professor Rangi Kandane-Rathnayake discuss the therapeutic strategies and emerging treatments in SLE and LN. This podcast provides a valuable framework for guiding therapeutic decisions for rare SLE manifestations where the available recommendations might be insufficient or inapplicable. The efficacy, PK and safety of iscalimab versus placebo as add-on to SoC therapy in p...

Discussing Lupus: Emerging therapies and renal outcomes in LN 03.10.2025

Join Professor Brad Rovin for an expert-led discussion focused on emerging therapies and renal outcomes in LN. This podcast will provide an overview of the effect of long-term voclosporin treatment on renal histology in patients with active LN with repeat renal biopsies, and explore how BCMA-targeted CAR T-cell therapy can effectively induce disease remission in refractory LN. If you are intereste...

Discussing Lupus: 2025 ACR Guideline for the Treatment of SLE 31.07.2025

Join Professors Ed Vital and Maria Dall’Era, and Doctor Guillermo J. Pons-Estel for an expert-led discussion focusing on the latest ACR 2025 SLE Guidelines. This podcast provides an overview of the latest treatment recommendations, as well as ungraded, consensus-based good practice statements that are applicable to children and adults with SLE. If you are interested in the paper discussed, head on...

cGAS Podcast 17.07.2025

Join Professors Ed Vital and Michelle Kahlenberg as they delve into the role of the cGAS pathway in systemic lupus erythematosus (SLE). This engaging discussion covers the pathway’s relevance in disease, recent clinical trial updates on cGAS inhibitors, and their potential role in the future treatment of SLE.

CAR-T and CAR-NK therapies: Are they the future of lupus treatment?: Highlights Podcast 11.07.2025

Join Professor Ed Vital, and Doctors Reuben Benjamin, Chris Wincup, and Marc Scherlinger on the Lupus Forum in their discussion on the recent webinar “CAR-T and CAR-NK therapies: Are they the future of lupus treatment?”. Watch them discuss key highlights from the webinar including the potential of CAR-T and CAR-NK therapies as transformative treatments for lupus. Highlighting the mechanisms, appli...

Lupus at EULAR: 2025 Review Podcast 20.06.2025

Join Professors Ed Vital and Chris Edwards as they review their highlights of the recent EULAR 2025 congress, watch them discuss their abstracts and highlight key information.

Poslouchej podcast The Lupus Forum v Replaio

Rádio a podcasty v jedné aplikaci - zdarma a bez registrace. Nainstaluj si ji ještě dnes a nepropásni premiéru

Stáhnout z Google Play

Replaio není vydavatelem podcastů; názvy pořadů, obálky a audio patří jejich autorům a šíří se přes veřejné RSS kanály